Public Meeting for Patient-Focused Drug Development on Opioid Use Disorder (OUD)

The Food and Drug Administration (FDA) is holding a public meeting to gather perspectives on OUD and its treatment. Individuals with OUD, family members, caregivers and advocates are invited to attend, either in person or digitally, and share their stories.

Apr 17 2018, 10:00am - 4:00pm EDT

Location: 

Food and Drug Administration: Silver Spring, MD